Verwaltungsgericht Köln kippt das Kava-Verbot

• Literatur

• 1 von Bonsdorff M, Törmäkangas T, Rantakokko M, et al. Barriers to outdoor physical activity and unmet physical activity need in older adults. Prev Med 2014. in press.
• 2 Holt S, Schmiedl S, Thürmann PA. PRISCUSListe potenziell inadäquater Medikation für ältere Menschen. http://priscus.net/download/PRISCUS-Liste_PRISCUS-TP3_2011.pdf .
• 3 Schwabe U, Paffrath D. Arzneiverordnungs-Report. 2000. Berlin, Heidelberg: Springer;
• 4 Teschke R. Hepatotoxicity by drugs and dietary supplements: safety perspectives on clinical and regulatory issues. Ann Hepatol 2009; 8: 184-195
• 5 Teschke R. Kava hepatotoxicity – a clinical review. Ann Hepatol 2010; 9: 251-265
• 6 Teschke R, Frenzel C, Glass X et al. Herbal hepatotoxicity: a critical review. Br J Clin Pharmacol 2013; 75: 630-636
• 7 Teschke R, Frenzel C, Schulze J, Eickhoff A. Herbal hepatotoxicity: Challenges and pitfalls of causality assessment methods. World J Gastroenterol 2013; 19: 2864-2882
• 8 Teschke R, Fuchs J, Bahre R et al. Kava hepatotoxicity: comparative study of two structured quantitative methods for causality assessment. J Clin Pharm Ther 2010; 35: 545-563
• 9 Teschke R, Schulze J. Pharmakovigilanz und herbale Hepatotoxizität: kritische Aspekte und Lösungswege. Dtsch Med Wochenschr 2013; 138: 281-284
• 10 Teschke R, Schwarzenboeck A, Hennermann KH. Causality assessment in hepatotoxicity by drugs and dietary supplements. Br J Clin Pharmacol 2008; 66: 758-766
• 11 Teschke R, Schwarzenboeck A, Hennermann KH. Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. Eur J Gastroenterol Hepatol 2008; 20: 1182-1193
• 12 Teschke R, Wolff A. Kava hepatotoxicity: regulatory data selection and causality assessment. Dig Liver Dis 2009; 41: 891-901
• 13 Teschke R, Wolff A. Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate?. Regul Toxicol Pharmacol 2011; 59: 1-7